Navigation Links
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
Date:4/18/2008

DETROIT, April 18 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (Amex: CPD) has confirmed that the United States District Court of New Jersey has granted Caraco's motion for summary judgment that the claims of U.S. Patent No. 39,221 that Ortho-McNeil Pharmaceutical, Inc. asserted against Caraco are invalid. Caraco's Tramadol with Acetaminophen product is a generic version of Ortho-McNeil's Ultracet(R). The Company commenced shipment of Tramadol with Acetaminophen following the FDA's approval to manufacture, market and distribute the generic product on December 19, 2005, and it has remained on the market since that time.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward- looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission and include, but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or cheaper products or new technology for the production of pr
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
2. Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
9. Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008
10. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Dr Roz Kamani, a Vancouver medical aesthetic doctor, ... patients an opportunity to learn more about the latest ... which is an exclusive VIP event conducted three times ... Clinic. It is attended by Dr Roz Kamani’s suppliers ... and services that are on offer. , In ...
(Date:4/1/2015)... OSF Saint Paul Medical Center, the newest member ... into the Ministry April 1, 2015, with a Blessing ... vicar general of the Catholic Diocese of Peoria. ... year-long transition process for the former Mendota Community Hospital, ... morning ceremony included Sister Judith Ann Duvall, O.S.F., Chairperson, ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Like a ... is the scientific understanding of the potential causes of ... by the National Rosacea Society (NRS) to educate the ... treatable facial disorder now estimated to affect more than ... supported medical research on rosacea through its patient-funded research ...
(Date:4/1/2015)... 01, 2015 eMindful , the ... of its executive team with the addition of veteran ... , In his new role, Suissa is ... interface across the business and consumer portals. He also ... the company’s online community. His hiring was a ...
(Date:4/1/2015)... When annoying or concerning skin conditions ... weeks for an appointment with a dermatologist is the ... appointments haven’t been possible within dermatology. However, in the ... noticed demand for this level of service and are ... relief or answers to dermatological issues are to our ...
Breaking Medicine News(10 mins):Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2
... means a shorter hospital stay and faster recovery for patients, ... the new bypass vessels will stay open. And, according to ... makes good economic sense for hospitals. The study will be ... , Using a surgical robot increases the cost of ...
... Mint to enhance brushing and easier oral cancer detection some ... of featured advancements, ... expected to attend the 2008 Spring Scientific,Session of the California Dental Association, ... 2, 2008 at 9:30am with a look,at the latest breaking technology on ...
... in the Workplace, 153 Workers Lose Their Lives,Another ... Organizers for the,annual Workers, Memorial Day sponsored ... Health (SoCalCOSH), UCLA-LOSH and WORKSAFE,along with many other ... through downtown Los Angeles in commemoration of fallen ...
... Southwest Regional Office,will participate in a press conference at ... for access to quality affordable health insurance for the,uninsured., ... government officials,as well as uninsured consumers. This event is ... to join legislative and local government,officials and consumers to ...
... Inc.,(Nasdaq: MEDX ) and Bristol-Myers Squibb Company ... with the U.S. Food and Drug Administration (FDA), ... submission for,ipilimumab, an investigational immunotherapy for patients with ... survival (OS),data to further demonstrate the benefit of ...
... April 25 Kyler Leinbach, a,9-year-old student ... Elementary School in Dauphin County, will receive ... the Pennsylvania Dental,Association,s (PDA) 2008 National Children,s ... Kyler,s poster will be reproduced as bookmarks, ...
Cached Medicine News:Health News:Study finds that minimally invasive robotic bypass surgery provides health and economic benefits 2Health News:Study finds that minimally invasive robotic bypass surgery provides health and economic benefits 3Health News:Dental Convention to Highlight Latest Breakthroughs in Oral Health Treatments 2Health News:Workers' Memorial Day Event to Stage Mock Public Funeral Procession to Pay Tribute to Fallen Workers 2Health News:Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab 2Health News:Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab 3Health News:Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab 4Health News:Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab 5Health News:Pennsylvania Dental Association Announces Winners of Annual Statewide Third-grade Student Poster Contest 2
(Date:4/1/2015)... , April 1, 2015 ... Report on Global Azithromycin Industry and 2015 ... Industry reports added to Pharmaceutical category in ... the report introduces Azithromycin basic information, including ... overview, policy analysis, and news analysis, etc. ...
(Date:4/1/2015)... 1, 2015  Boston Scientific Corporation (NYSE: BSX ) ... at 8 a.m. ET to review financial results and business ... a news release announcing first quarter financial results prior to ... by Mike Mahoney , president and chief executive officer, ... financial officer. A live webcast of the conference ...
(Date:4/1/2015)... Mar. 30, 2015 Research and Markets ... of the "Medical Device Studies: Clinical Evidence" ... course has been designed specifically for those who ... medical devices and in-vitro diagnostic products. Clinical data ... emphasis on high quality, appropriate clinical evidence has ...
Breaking Medicine Technology:Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results 2Medical Device Studies: Clinical Evidence Seminar - London, UK, 13th, 14th of May 2015 2
... Inc. (NYSE: MTD ) today announced the webcast ... in New York on Wednesday, September 21, 2011, at 9:00 ... presentation, visit the investor relations page on the Company,s Web ... will be available for seven days. METTLER TOLEDO ...
... JERUSALEM, Sept. 14, 2011 Chiasma, Inc., a privately held ... will present an overview of the Company at the UBS ... New York, on Monday, September 19, 2011 at 1:30 PM. ... form of octreotide acetate being developed first for the oral ...
Cached Medicine Technology:Chiasma to Present at the UBS Global Life Sciences Conference 2
... industry's most powerful, comprehensive and most ... fact, OfficeMate is the most widely ... one out of every three computerized ... care of all your practice management ...
Easy-to-use and afforable practice management software. For more details, please contact First Insight....
Easy to use practice management software....
... Insight is the leading practice management ... eye care professionals. MaximEyes was the ... servicesrequest VSP authorizations, submit claims and ... scheduling, billing, demographics, recall, insurance, point-of-sale, ...
Medicine Products: